Global pharmaceutical service provider for Regulatory Affairs, GMP Compliance, Audits, CDMO Services and Supply Chain
PharmSol Group (Pharmaceutical Solutions DMCC)
Dubai (AE) · Bad Oldesloe (DE) · Nanjing (CN) · Hong Kong (CN) · Hyderabad (IN) · Mosta (MT)New on Amplifa
About PharmSol
Founded in 2004, PharmSol is a global pharmaceutical service provider headquartered in Dubai (Jumeirah Lakes Towers). The company offers integrated solutions through a single point of contact ('single window') for pharmaceutical and biotech customers as well as generics manufacturers. The service portfolio covers GMP/QP audits, EU GMP certification, USFDA compliance, Regulatory Affairs & Market Access, biosimilar development, facility design and project management, sourcing & supply chain, and Contract Development & Manufacturing (CDMO) for APIs and finished dosage forms (FDFs). PharmSol works with a worldwide network of manufacturers and supports technology transfers, approvals and product supply, including in patent-free territories. Locations exist in Dubai, Bad Oldesloe (Germany), Nanjing and Hong Kong (China), Hyderabad (India) and Mosta (Malta). Customers include, among others, Caelo (Caesar & Loretz GmbH) and Sasha.
- Site
- Dubai
- Processes
- Contract Development & Manufacturing (CDMO) of pharmaceutical products, Technology Transfer, GMP/QP Audits, EU GMP Certification, Regulatory & Market Access, USFDA Compliance & Regulatory, Compliance Solutions, Biosimilar Development (End-to-End)
- Materials
- APIs (Active Pharmaceutical Ingredients), FDFs (Finished Dosage Forms), Biosimilars, Medical Devices, Dietary Supplements
- Certificates
- APIC/CEFIC/ASQ Certified Auditors (Team Certification), APIC/CEFIC/ASQ Certified Auditors (Team)
- Founded
- 2004
- Employees
- 51-200
- Industries
- Pharmaceutical Industry, Biotech, Generics Manufacturers
- 01
Product Development (APIs/FDFs)
- 02
Regulatory & Approvals
- 03
Technology Transfer
- 04
Contract Development & Manufacturing
- 05
Sourcing & Supply Chain
- 06
GMP Compliance & Audits
Products & Development Objects
APIs (Active Pharmaceutical Ingredients)
Development, approval and supply of pharmaceutical active ingredients.
FDFs (Finished Dosage Forms)
Development and licensing of finished dosage forms via a global manufacturing network.
Biosimilars
End-to-end support from development to marketing of biosimilars.
Medical Devices
Development, manufacturing and supply of medical devices.
Dietary Supplements
Development and supply of dietary supplements.
Locations
Dubai
AEHeadquarters (Jumeirah Lakes Towers, Tiffany Tower)
Bad Oldesloe
DEBranch Office (Brunnenstr. 1)
Nanjing
CNBranch Office (Jiangning District, Future Science and Technology City)
Hyderabad
INBranch Office (Madhapur, Hitech City)
Mosta
MTBranch Office (Valletta Road, The Victoria Centre)
Hong Kong
CNBranch Office (Connaught Road Central)
Services & Product Areas
Inside the production
Industries
Processes & technical limits
| Processes | Tolerance | Max. part | Weight | Lot size | Materials |
|---|---|---|---|---|---|
| Contract Development & Manufacturing (CDMO) of pharmaceutical productsEngineering | – | – | – | – | APIs, FDFs |
| Technology TransferEngineering | – | – | – | – | – |
| GMP/QP AuditsTesting | – | – | – | – | – |
| EU GMP CertificationTesting | – | – | – | – | – |
| Regulatory & Market AccessEngineering | – | – | – | – | – |
| USFDA Compliance & RegulatoryTesting | – | – | – | – | – |
| Compliance SolutionsTesting | – | – | – | – | – |
| Biosimilar Development (End-to-End)Engineering | – | – | – | – | – |
| Facility Design & Project ManagementEngineering | – | – | – | – | – |
| Sourcing & Supply ChainAssembly | – | – | – | – | – |
Additional services
Reference customers
Quality & Compliance
PharmSol deploys a team of APIC/CEFIC/ASQ-certified auditors and maintains an extensive audit library. The experts support customers on-site with compliance preparation for authority inspections such as USFDA, EU and TGA.
| Evidence | Dubai |
|---|---|
| APIC/CEFIC/ASQ Certified Auditors (Team) |
History
- 2004
Founding of PharmSol
- 2025
Participation in CPHI Frankfurt